![Ilse Roodink](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ilse Roodink formerly worked at ImmunoPrecise Antibodies (Europe) BV, as Scientific Director and MindWalk Holdings Corp., as Chief Scientific Officer from 2021 to 2025.
Dr. Roodink received her undergraduate degree, graduate degree, and doctorate degree from Radboud University Nijmegen.
Ehemalige bekannte Positionen von Ilse Roodink
| Unternehmen | Position | Ende |
|---|---|---|
| MINDWALK HOLDINGS CORP. | Technik-/Wissenschafts-/F&E-Leiter | 06.08.2025 |
Immunoprecise Antibodies (Europe) BV
 Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in antibiotics | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Ilse Roodink
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
19
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Radboud University Nijmegen
 Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmunoPrecise Antibodies Ltd.
 ImmunoPrecise Antibodies Ltd. BiotechnologyHealth Technology Operates as AI-driven biotherapeutic research and technology firm that develops & discovers antibodies | Health Technology |
Immunoprecise Antibodies (Europe) BV
Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in antibiotics | Health Technology |
